Skip to main content
    • Aa
    • Aa

Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications

  • J. Alexandra Rowe (a1), Antoine Claessens (a1), Ruth A. Corrigan (a1) and Mònica Arman (a1)

Severe malaria has a high mortality rate (15–20%) despite treatment with effective antimalarial drugs. Adjunctive therapies for severe malaria that target the underlying disease process are therefore urgently required. Adhesion of erythrocytes infected with Plasmodium falciparum to human cells has a key role in the pathogenesis of life-threatening malaria and could be targeted with antiadhesion therapy. Parasite adhesion interactions include binding to endothelial cells (cytoadherence), rosetting with uninfected erythrocytes and platelet-mediated clumping of infected erythrocytes. Recent research has started to define the molecular mechanisms of parasite adhesion, and antiadhesion therapies are being explored. However, many fundamental questions regarding the role of parasite adhesion in severe malaria remain unanswered. There is strong evidence that rosetting contributes to severe malaria in sub-Saharan Africa; however, the identity of other parasite adhesion phenotypes that are implicated in disease pathogenesis remains unclear. In addition, the possibility of geographic variation in adhesion phenotypes causing severe malaria, linked to differences in malaria transmission levels and host immunity, has been neglected. Further research is needed to realise the untapped potential of antiadhesion adjunctive therapies, which could revolutionise the treatment of severe malaria and reduce the high mortality rate of the disease.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications
      Available formats
Corresponding author
*Corresponding author: J. Alexandra Rowe, Institute of Immunology and Infection Research, King's Buildings, University of Edinburgh, West Mains Rd, Edinburgh, EH9 3JT, UK. Tel: +44 131 6505492; Fax: +44-131-6506564; E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1R.W. Snow (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434, 214-217

2K. Marsh (1995) Indicators of life-threatening malaria in African children. New England Journal of Medicine 332, 1399-1404

3A.M. Dondorp (2008) The relationship between age and the manifestations of and mortality associated with severe malaria. Clinical Infectious Diseases 47, 151-157

4L.H. Miller (2002) The pathogenic basis of malaria. Nature 415, 673-679

5A.M. Dondorp (2008) Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. Journal of Infectious Diseases 197, 79-84

6A.M. Dondorp , E. Pongponratn and N.J. White (2004) Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electron-microscopic pathology. Acta Tropica 89, 309-317

7T. Planche and S. Krishna (2006) Severe malaria: metabolic complications. Current Molecular Medicine 6, 141-153

8L. Schofield (2007) Intravascular infiltrates and organ-specific inflammation in malaria pathogenesis. Immunology and Cell Biology 85, 130-137

9H.C. van der Heyde (2006) A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends in Parasitology 22, 503-508

10R.E. Mebius and G. Kraal (2005) Structure and function of the spleen. Nature Reviews Immunology 5, 606-616

11I.J. Udeinya (1981) Falciparum malaria-infected erythrocytes specifically bind to cultured human endothelial cells. Science 213, 555-557

12R. Udomsangpetch (1989) Plasmodium falciparum-infected erythrocytes form spontaneous erythrocyte rosettes. Journal of Experimental Medicine 169, 1835-1840

13A. Pain (2001) Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. Proceedings of the National Academy of Sciences of the United States of America 98, 1805-1810

14R.S. Bray and R.E. Sinden (1979) The sequestration of Plasmodium falciparum infected erythrocytes in the placenta. Transactions of the Royal Society of Tropical Medicine and Hygiene 73, 716-719

15S.J. Rogerson (2007) Malaria in pregnancy: pathogenesis and immunity. Lancet Infectious Diseases 7, 105-117

17J.A. Rowe and S.A. Kyes (2004) The role of Plasmodium falciparum var genes in malaria in pregnancy. Molecular Microbiology 53, 1011-1019

19O.A. Erunkulu (1992) Severe malaria in Gambian children is not due to lack of previous exposure to malaria. Clinical and Experimental Immunology 89, 296-300

20K. Chotivanich (2000) Parasite multiplication potential and the severity of Falciparum malaria. Journal of Infectious Diseases 181, 1206-1209

21J.A. Simpson (1999) Red cell selectivity in malaria: a study of multiple-infected erythrocytes. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 165-168

23J.W. Field and J.C. Niven (1937) A note on prognosis in relation to parasite counts in acute subtertian malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 30, 569-574

24A.M. Dondorp (2005) Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Medicine 2, e204

26J. Carlson (1990) Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336, 1457-1460

31J.F. Kun (1998) Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambarene, Gabon. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 110-114

32A. Heddini (2001) Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors. Infection and Immunity 69, 5849-5856

37K. Chotivanich (2004) Platelet-induced autoagglutination of Plasmodium falciparum-infected red blood cells and disease severity in Thailand. Journal of Infectious Diseases 189, 1052-1055

38D.I. Baruch (1995) Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitised human erythrocytes. Cell 82, 77-87

39J.D. Smith (1995) Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82, 101-110

40X.-Z. Su (1995) A large and diverse family gene family (var) encodes 200-350 kD proteins implicated in the antigenic variation and cytoadherence of Plasmodium falciparum-infected erythocytes. Cell 82, 89-99

41S.A. Kyes (1999) Rifins: A second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America 96, 9333-9338

42J.E. Blythe (2008) Plasmodium falciparum STEVOR proteins are highly expressed in patient isolates and located in the surface membranes of infected red blood cells and the apical tips of merozoites. Infection and Immunity 76, 3329-3336

43J.D. Smith (2000) Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family. Molecular and Biochemical Parasitology 110, 293-310

44B.A. Robinson , T.L. Welch and J.D. Smith (2003) Widespread functional specialization of Plasmodium falciparum erythrocyte membrane protein 1 family members to bind CD36 analysed across a parasite genome. Molecular Microbiology 47, 1265-1278

45M. Kaestli (2006) Virulence of malaria is associated with differential expression of Plasmodium falciparum var gene subgroups in a case-control study. Journal of Infectious Diseases 193, 1567-1574

46H.M. Kyriacou (2006) Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia. Molecular and Biochemical Parasitology 150, 211-218

47S.A. Kyes , S.M. Kraemer and J.D. Smith (2007) Antigenic Variation in Plasmodium falciparum: Gene Organization and Regulation of the var Multigene Family. Eukaryotic Cell 6, 1511-1520

48S.M. Kraemer and J.D. Smith (2006) A family affair: var genes, PfEMP1 binding, and malaria disease. Current Opinion in Microbiology 9, 374-380

49J.D. Smith (2001) Decoding the language of var genes and Plasmodium falciparum sequestration. Trends in Parasitology 17, 538-545

50D.J. Roberts (1992) Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357, 689-692

53C.J. McCormick (1997) Intercellular adhesion molecule-1 and CD36 synergize to mediate adherence of Plasmodium falciparum-infected erythrocytes to cultured human microvascular endothelial cells. Journal of Clinical Investigation 100, 2521-2529

54B.G. Yipp (2007) Differential roles of CD36, ICAM-1, and P-selectin in Plasmodium falciparum cytoadherence in vivo. Microcirculation 14, 593-602

55M. Ho (2000) Visualization of Plasmodium falciparum-endothelium interactions in human microvasculature: mimicry of leukocyte recruitment. Journal of Experimental Medicine 192, 1205-1211

57P. Oquendo (1989) CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell 58, 95-101

58J.W. Barnwell (1989) A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. Journal of Clinical Investigation 84, 765-772

60L. Daviet (1997) Characterization of two vaccinia CD36 recombinant-virus-generated monoclonal antibodies (10/5, 13/10): effects on malarial cytoadherence and platelet functions. European Journal of Biochemistry 243, 344-349

62D.I. Baruch (1996) Plasmodium falciparum erythocyte membrane protein 1 is a parasitised erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. Proceedings of the National Academy of Sciences of the United States of America 93, 3497-3502

63L.H. Miller (2002) Definition of the minimal domain of CIDR1alpha of Plasmodium falciparum PfEMP1 for binding CD36. Molecular and Biochemical Parasitology 120, 321-323

64J.D. Smith (1998) Analysis of adhesive domains from the A4VAR Plasmodium falciparum erythrocyte membrane protein-1 identifies a CD36 binding domain. Molecular and Biochemical Parasitology 97, 133-148

66M.M. Klein (2008) The cysteine-rich interdomain region from the highly variable Plasmodium falciparum erythrocyte membrane protein-1 exhibits a conserved structure. PLoS Pathogens 4, e1000147

67L. Serghides (2003) CD36 and malaria: friends or foes? Trends in Parasitology 19, 461-469

68K. Marsh (1988) Plasmodium falciparum: the behavior of clinical isolates in an in vitro model of infected red blood cell sequestration. Experimental Parasitology 65, 202-208

72C.F. Ockenhouse (1991) Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. Journal of Infection Dis 164, 163-169

73K. Omi (2003) CD36 polymorphism is associated with protection from cerebral malaria. American Journal of Human Genetics 72, 364-374

74A.R. Berendt (1989) Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 341, 57-59

75S.J. Chakravorty and A. Craig (2005) The role of ICAM-1 in Plasmodium falciparum cytoadherence. European Journal of Cell Biology 84, 15-27

76A.R. Berendt (1992) The binding site on ICAM-1 for Plasmodium falciparum-infected erythrocytes overlaps, but is distinct from, the LFA-1-binding site. Cell 68, 71-81

77C.F. Ockenhouse (1992) Plasmodium falciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA-1, Mac-1, and human rhinovirus. Cell 68, 63-69

78M.T. Tse (2004) Divergent binding sites on intercellular adhesion molecule-1 (ICAM-1) for variant Plasmodium falciparum isolates. Molecular Microbiology 51, 1039-1049

79J.D. Smith (2000) Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria. Proceedings of the National Academy of Sciences of the United States of America 97, 1766-1771

80R. Chattopadhyay (2004) Molecular analysis of the cytoadherence phenotype of a Plasmodium falciparum field isolate that binds intercellular adhesion molecule-1. Molecular and Biochemical Parasitology 133, 255-265

81A.L. Springer (2004) Functional interdependence of the DBLbeta domain and c2 region for binding of the Plasmodium falciparum variant antigen to ICAM-1. Molecular and Biochemical Parasitology 137, 55-64

82D.P. Howell (2008) Mapping a common interaction site used by Plasmodium falciparum Duffy binding-like domains to bind diverse host receptors. Molecular Microbiology 67, 78-87

83A. Craig (2000) A functional analysis of a natural variant of intercellular adhesion molecule-1 (ICAM-1Kilifi). Human Molecular Genetics 9, 525-530

84D. Fernandez-Reyes (1997) A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Human Molecular Genetics 6, 1357-1360

85N.E. Jenkins (2005) A polymorphism of intercellular adhesion molecule-1 is associated with a reduced incidence of nonmalarial febrile illness in Kenyan children. Clinical Infectious Diseases 41, 1817-1819

87D. Kwiatkowski (1990) TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336, 1201-1204

89A.M. Senczuk (2001) Plasmodium falciparum erythrocyte membrane protein 1 functions as a ligand for P-selectin. Blood 98, 3132-3135

90D.D. Roberts (1985) Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence. Nature 318, 64-66

92S. Eda , J. Lawler and I.W. Sherman (1999) Plasmodium falciparum-infected erythrocyte adhesion to the type 3 repeat domain of thrombospondin-1 is mediated by a modified band 3 protein. Molecular and Biochemical Parasitology 100, 195-205

93S. Eda and I.W. Sherman (2002) Cytoadherence of malaria-infected red blood cells involves exposure of phosphatidylserine. Cellular Physiology and Biochemistry 12, 373-384

94C.J. Treutiger (1997) PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes. Nature Medicine 3, 1405-1408

95Q. Chen (2000) The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. Journal of Experimental Medicine 192, 1-10

97M. Kikuchi (2001) Association of adhesion molecule PECAM-1/CD31 polymorphism with susceptibility to cerebral malaria in Thais. Parasitology International 50, 235-239

98C.F. Ockenhouse (1992) Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. Journal of Experimental Medicine 176, 1183-1189

99A.M. Vogt (2003) Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1. Blood 101, 2405-2411

101M.A. Skidmore (2008) Disruption of rosetting in Plasmodium falciparum malaria with chemically modified heparin and low molecular weight derivatives possessing reduced anticoagulant and other serine protease inhibition activities. Journal of Medicinal Chemistry 51, 1453-1458

102Q. Chen (1998) Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum. Journal of Experimental Medicine 187, 15-23

103T. Hatabu (2003) Binding of Plasmodium falciparum-infected erythrocytes to the membrane-bound form of Fractalkine/CX3CL1. Proceedings of the National Academy of Sciences of the United States of America 100, 15942-15946

105S. Eda and I.W. Sherman (2004) Plasmodium falciparum-infected erythrocytes bind to the RGD motif of fibronectin via the band 3-related adhesin. Experimental Parasitology 107, 157-162

106B. Pouvelle (2007) Neural cell adhesion molecule, a new cytoadhesion receptor for Plasmodium falciparum-infected erythrocytes capable of aggregation. Infection and Immunity 75, 3516-3522

107A.K. Biswas (2007) Plasmodium falciparum uses gC1qR/HABP1/p32 as a receptor to bind to vascular endothelium and for platelet-mediated clumping. PLoS Pathogens 3, 1271-1280

108P. Pino (2003) Plasmodium falciparum-infected erythrocyte adhesion induces caspase activation and apoptosis in human endothelial cells. Journal of Infectious Diseases 187, 1283-1290

109N.O. Wilson (2008) Soluble factors from Plasmodium falciparum-infected erythrocytes induce apoptosis in human brain vascular endothelial and neuroglia cells. Molecular and Biochemical Parasitology 162, 172-176

110T.W. Yeo (2007) Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. Journal of Experimental Medicine 204, 2693-2704

111J.B. Weinberg (2008) Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria. Current Opinion in Infectious Diseases 21, 468-475

112S. Serirom (2003) Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow. American Journal of Pathology 162, 1651-1660

113I.M. Francischetti (2007) Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes. Journal of Thrombosis and Haemostasis 5, 155-165

116J.A. Rowe (1997) P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388, 292-295

117J.A. Rowe (2000) Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates. Journal of Immunology 165, 6341-6346

118J. Carlson and M. Wahlgren (1992) Plasmodium falciparum erythrocyte rosetting is mediated by promiscuous lectin-like interactions. Journal of Experimental Medicine 176, 1311-1317

120C. Russell (2005) Further definition of PfEMP-1 DBL-1alpha domains mediating rosetting adhesion of Plasmodium falciparum. Molecular and Biochemical Parasitology 144, 109-113

121I. Vigan-Womas (2008) An in vivo and in vitro model of Plasmodium falciparum rosetting and autoagglutination mediated by varO, a group A var gene encoding a frequent serotype. Infection and Immunity 76, 5565-5580

122C. Scholander (1996) Novel fibrillar structure confers adhesive property to malaria-infected erythrocytes. Nature Medicine 2, 204-208

123C.J. Treutiger (1999) Rouleaux-forming serum proteins are involved in the rosetting of Plasmodium falciparum-infected erythrocytes. Experimental Parasitology 93, 215-224

124A. Ghumra (2008) Identification of residues in the Cmu4 domain of polymeric IgM essential for interaction with Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1). Journal of Immunology 181, 1988-2000

126R. Khera and N. Das (2009) Complement Receptor 1: Disease associations and therapeutic implications. Molecular Immunology 46, 761-772

127I.A. Cockburn (2004) A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proceedings of the National Academy of Sciences of the United States of America 101, 272-277

129P. Teeranaipong (2008) A functional single-nucleotide polymorphism in the CR1 promoter region contributes to protection against cerebral malaria. Journal of Infectious Diseases 198, 1880-1891

131A. Barragan (2000) Blood group A antigen is a coreceptor in Plasmodium falciparum rosetting. Infection and Immunity 68, 2971-2975

133J.A. Rowe (2007) Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proceedings of the National Academy of Sciences of the United States of America 104, 17471-17476

134A.E. Fry (2008) Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria. Human Molecular Genetics 17, 567-576

135S.L. Pathirana (2005) ABO-blood-group types and protection against severe, Plasmodium falciparum malaria. Annals of Tropical Medicine and Parasitology 99, 119-124

136A.M. Vogt (2004) Heparan sulphate identified on human erythrocytes: a Plasmodium falciparum receptor. Biochemical Journal 381, 593-597

137S.C. Wassmer (2004) Platelets reorient Plasmodium falciparum-infected erythrocyte cytoadhesion to activated endothelial cells. Journal of Infectious Diseases 189, 180-189

138K. Srivastava (2008) Platelet factor 4 mediates inflammation in experimental cerebral malaria. Cell Host and Microbe 4, 179-187

139G.E. Grau (2003) Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. Journal of Infectious Diseases 187, 461-466

140B.J. McMorran (2009) Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science 323, 797-800

141S.C. Wassmer (2008) Platelet-induced clumping of Plasmodium falciparum-infected erythrocytes from Malawian patients with cerebral malaria-possible modulation in vivo by thrombocytopenia. Journal of Infectious Diseases 197, 72-78

143M. Arman and J.A. Rowe (2008) Experimental conditions affect the outcome of Plasmodium falciparum platelet-mediated clumping assays. Malaria Journal 7, 243

146B.C. Urban , N. Willcox and D.J. Roberts (2001) A role for CD36 in the regulation of dendritic cell function. Proceedings of the National Academy of Sciences of the United States of America 98, 8750-8755

147S.R. Elliott (2007) Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1. Infection and Immunity 75, 3621-3632

148D. Donati (2004) Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infection and Immunity 72, 5412-5418

149K. Artavanis-Tsakonas (2003) Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes. Journal of Immunology 171, 5396-5405

150M. Baratin (2007) Dissection of the role of PfEMP1 and ICAM-1 in the sensing of Plasmodium falciparum-infected erythrocytes by natural killer cells. PLoS ONE 2, e228

151M.C. D'Ombrain (2007) Plasmodium falciparum erythrocyte membrane protein-1 specifically suppresses early production of host interferon-gamma. Cell Host and Microbe 2, 130-138

153T.E. Taylor (2004) Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nature Medicine 10, 143-145

154A.M. Dondorp (2008) Clinical significance of sequestration in adults with severe malaria. Transfusion Clinique et Biologique 15, 56-57

155K. Artavanis-Tsakonas , J.E. Tongren and E.M. Riley (2003) The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clinical and Experimental Immunology 133, 145-152

156I.M. Francischetti (2008) Does activation of the blood coagulation cascade have a role in malaria pathogenesis? Trends in Parasitology 24, 258-263

157K.B. Seydel (2006) The distribution and intensity of parasite sequestration in comatose Malawian children. Journal of Infectious Diseases 194, 208–205

159F. Bruneel (2003) The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults. American Journal of Respiratory and Critical Care Medicine 167, 684-689

161T.S. Skinner (1996) In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. International Journal for Parasitology 26, 519-525

163P.E. Duffy , A.G. Craig and D.I. Baruch (2001) Variant proteins on the surface of malaria-infected erythrocytes–developing vaccines. Trends in Parasitology 17, 354-356

164D.I. Baruch (2002) Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line. Proceedings of the National Academy of Sciences of the United States of America 99, 3860-3865

165Q. Chen (2004) Immunization with PfEMP1-DBL1alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes. Vaccine 22, 2701-2712

166B. Gamain , L.H. Miller and D.I. Baruch (2001) The surface variant antigens of Plasmodium falciparum contain cross-reactive epitopes. Proceedings of the National Academy of Sciences of the United States of America 98, 2664-2669

167D.I. Baruch , B. Gamain and L.H. Miller (2003) DNA immunization with the cysteine-rich interdomain region 1 of the Plasmodium falciparum variant antigen elicits limited cross-reactive antibody responses. Infection and Immunity 71, 4536-4543

168S. Gandon (2003) Imperfect vaccination: some epidemiological and evolutionary consequences. Proceedings of the Royal Society B Biological Sciences 270, 1129-1136

169B.G. Yipp (2003) Src-family kinase signaling modulates the adhesion of Plasmodium falciparum on human microvascular endothelium under flow. Blood 101, 2850-2857

170M. Ho (2005) Ectophosphorylation of CD36 regulates cytoadherence of Plasmodium falciparum to microvascular endothelium under flow conditions. Infection and Immunity 73, 8179-8187

171A.M. Dondorp (2007) Levamisole inhibits sequestration of infected red blood cells in patients with falciparum malaria. Journal of Infectious Diseases 196, 460-466

172P. Gruarin (2001) Cytoadherence of Plasmodium falciparum-infected erythrocytes is mediated by a redox-dependent conformational fraction of CD36. Journal of Immunology 167, 6510-6517

175G. Watt , K. Jongsakul and R. Ruangvirayuth (2002) A pilot study of N-acetylcysteine as adjunctive therapy for severe malaria. Quarterly Journal of Medicine 95, 285-290

177P. Arreesrisom (2007) Suppressive effects of the anti-oxidant N-acetylcysteine on the anti-malarial activity of artesunate. Parasitology International 56, 221-226

178B.M. Cooke (1998) A recombinant peptide based on PfEMP-1 blocks and reverses adhesion of malaria-infected red blood cells to CD36 under flow. Molecular Microbiology 30, 83-90

179B.G. Yipp (2003) Recombinant PfEMP1 peptide inhibits and reverses cytoadherence of clinical Plasmodium falciparum isolates in vivo. Blood 101, 331-337

180M. Dormeyer (2006) Rational design of anticytoadherence inhibitors for Plasmodium falciparum based on the crystal structure of human intercellular adhesion molecule 1. Antimicrobial Agents and Chemotherapy 50, 724-730

181R. Benelli (2002) Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Biological Chemistry 383, 101-105

182G. Fassina (2004) Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clinical Cancer Research 10, 4865-4873

183Y. Yoda (2004) Different susceptibilities of Staphylococcus and Gram-negative rods to epigallocatechin gallate. Journal of Infection and Chemotherapy 10, 55-58

184N.M. Anstey (1996) Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. Journal of Experimental Medicine 184, 557-567

185B.K. Lopansri (2003) Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production. Lancet 361, 676-678

186T.W. Yeo (2008) Pharmacokinetics of L-arginine in adults with moderately severe malaria. Antimicrobial Agents and Chemotherapy 52, 4381-4387

187T.W. Yeo (2008) Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations. Journal of Infectious Diseases 198, 602-608

188T.W. Yeo (2008) Safety profile of L-arginine infusion in moderately severe falciparum malaria. PLoS ONE 3, e2347

189Z. Taoufiq (2008) Rho kinase inhibition in severe malaria: thwarting parasite-induced collateral damage to endothelia. Journal of Infectious Diseases 197, 1062-1073

191A. Rowe (1994) Plasmodium falciparum: a family of sulphated glycoconjugates disrupts erythrocyte rosettes. Experimental Parasitology 79, 506-516

193A.M. Vogt (2006) Release of sequestered malaria parasites upon injection of a glycosaminoglycan. PLoS Pathogens 2, e100

194H.M. Kyriacou (2007) In vitro inhibition of Plasmodium falciparum rosette formation by Curdlan sulfate. Antimicrobial Agents and Chemotherapy 51, 1321-1326

196I. Havlik (2005) Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 99, 333-340

197H.F. Weisman (1990) Soluble human complement receptor type I: In vivo inhibitor of complement suppressing post-ischaemic myocardial inflammation and necrosis. Science 249, 146-151

198S. Keshavjee (2005) A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings. Journal of Thoracic and Cardiovascular Surgery 129, 423-428

200I. Ahrens , C. Bode and K. Peter (2005) Inhibition of platelet activation and aggregation. Handbook of Experimental Pharmacology 443-462

201J.S. Bennett (2001) Novel platelet inhibitors. Annual Review of Medicine 52, 161-184

202M. Nacher (2001) Case-control studies on host factors in severe malaria. Trends in Parasitology 17, 253-254

203J. Montgomery (2006) Genetic Analysis of Circulating and Sequestered Populations of Plasmodium falciparum in Fatal Pediatric Malaria. Journal of Infectious Diseases 194, 115-122

204S. Krishna (1994) Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 67-73

206C. Le Scanf (2008) Rosetting is associated with increased Plasmodium falciparum in vivo multiplication rate in the Saimiri sciureus monkey. Microbes and Infection 10, 447-451

207B. Clough , F.A. Atilola and G. Pasvol (1998) The role of rosetting in the multiplication of Plasmodium falciparum: rosette formation neither enhances nor targets parasite invasion into uninfected red cells. British Journal of Haematology 100, 99-104

208A.M. Deans and J.A. Rowe (2006) Plasmodium falciparum: Rosettes do not protect merozoites from invasion-inhibitory antibodies. Experimental Parasitology 112, 269-273

209P.H. David (1983) Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. Proceedings of the National Acadamy of Science of the United States of America 80, 5075-5079

210K. Willimann (1995) In vivo sequestration of Plasmodium falciparum-infected human erythrocytes: a severe combined immunodeficiency mouse model for cerebral malaria. Journal of Experimental Medicine 182, 643-653

211F. Pettersson (2005) Whole-body imaging of sequestration of Plasmodium falciparum in the rat. Infection and Immunity 73, 7736-7746

212R.S. McIntosh (2007) The importance of human FcgammaRI in mediating protection to malaria. PLoS Pathogens 3, e72

213D.L. Simmons (2005) Anti-adhesion therapies. Current Opinion in Pharmacology 5, 398-404

214T.J. Aitman (2000) Malaria susceptibility and CD36 mutation. Nature 405, 1015-1016

215G. Ayodo (2007) Combining evidence of natural selection with association analysis increases power to detect malaria-resistance variants. American Journal of Human Genetics 81, 234-242

216O.K. Amodu (2005) Plasmodium falciparum malaria in south-west Nigerian children: is the polymorphism of ICAM-1 and E-selectin genes contributing to the clinical severity of malaria? Acta Tropica 95, 248-255

217A. Pain (2001) A non-sense mutation in Cd36 gene is associated with protection from severe malaria. Lancet 357, 1502-1503

218R. Bellamy , D. Kwiatkowski and A.V. Hill (1998) Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 312-316

219R. Ndiaye (2005) Genetic study of ICAM1 in clinical malaria in Senegal. Tissue Antigens 65, 474-480

220A.E. Fry (2008) Variation in the ICAM1 gene is not associated with severe malaria phenotypes. Genes and Immunity 9, 462-469

222J.M. Moulds (2001) Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 97, 2879-2885

223V. Thathy (2005) Complement receptor 1 polymorphisms associated with resistance to severe malaria in Kenya. Malaria Journal 4, 54

224P.A. Zimmerman (2003) CR1 Knops blood group alleles are not associated with severe malaria in the Gambia. Genes and Immunity 4, 368-373

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score